| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2006 | WO2005112907A3 Nontoxic killer of e. coli and other problem microorganisms |
| 04/13/2006 | WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines |
| 04/13/2006 | WO2005105066A8 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis, cardiovascular diseases |
| 04/13/2006 | WO2005103052A8 Pyrazolo [1,5-a] pyrimidin-7-one compounds and uses thereof |
| 04/13/2006 | WO2005099824A8 1-glyoxylamide indolizines for treating lung and ovarian cancer |
| 04/13/2006 | WO2005097077A3 Spray dried pharmaceutical compositions |
| 04/13/2006 | WO2005094798A3 Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists |
| 04/13/2006 | WO2005090572A3 Compositions and methods for treating pancreatic cancer |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | WO2005084157A3 Methods of treating disease through the administration of a manzamine analog or derivative |
| 04/13/2006 | WO2005082329A3 Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide |
| 04/13/2006 | WO2005074983A3 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 04/13/2006 | WO2005067893A3 Pharmaceutical compositions comprising midazolam in a high concentration |
| 04/13/2006 | WO2005063785A3 Glucopyranosyloxy-substituted aromates, medicaments containing said compounds, the use thereof, and methods for producing the same |
| 04/13/2006 | WO2005063256A3 Coating method |
| 04/13/2006 | WO2005060342A3 Cysteamine compounds for treating allergy |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | WO2005030167A3 Buccal, polar and non-polar spray containing alprazolam |
| 04/13/2006 | WO2005009392A3 Dihydropyrimidone inhibitors of calcium channel function |
| 04/13/2006 | WO2005000213A3 Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors |
| 04/13/2006 | WO2004019882A3 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS |
| 04/13/2006 | WO2002038576A1 ARYL PHOSPHATE DERIVATIVES OF d4T |
| 04/13/2006 | US20060080744 Novel chemokine-like polypeptides |
| 04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079706 N-[4-cyano-3-(trifluoro-methyl) phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide in crystalline form and amorphous bicalutamide; for use in treatment of prostate cancer |
| 04/13/2006 | US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079633 High stability and resistance to syneresis; deodorants, antiperspirant, lotions,soapa; drug delivery; personal care |
| 04/13/2006 | US20060079582 Memantine for the treatment of childhood behavioral disorders |
| 04/13/2006 | US20060079581 Polymorphs of atomoxetine hydrochloride |
| 04/13/2006 | US20060079580 Production of mutant strain of aspergillus fumigatus, method of assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection |
| 04/13/2006 | US20060079579 Combinations of valsartan with cox-2 inhibitors |
| 04/13/2006 | US20060079578 Comprises 3-amino-1-propanesulfonic acid for reducing/preventing gastrointestinal intolerance; treating Alzheimer's disease, cerebral amyloid angiopathy, inclusion body myositis, macular degeneration, Down's syndrome, mild cognitive impairment, and hereditary cerebral hemorrhage; side effects reduction |
| 04/13/2006 | US20060079577 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/13/2006 | US20060079576 2-methoxyestradiol in a biodegradable polymer; administered for treatment of tumors |
| 04/13/2006 | US20060079575 Anticancer agent for drug resistant cancer |
| 04/13/2006 | US20060079574 Methods of treating mental diseases, inflammation and pain |
| 04/13/2006 | US20060079573 Methods and compositions for preventing vasospasm |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079571 Antitumor agents; High yield and High Purity without chromatographic purifications; novel intermediates compound(VII) and (VIII); esterification of 10-deacetylbaccatins with oxazolidines; hydrolysis; acid treatment; reaction with di-tert-butyl dicarbonate in solvents like alcohols in the absence of bases |
| 04/13/2006 | US20060079570 Alpha-aminoamide derivatives useful as antimigraine agents |
| 04/13/2006 | US20060079569 Antidepressant oral liquid compositions |
| 04/13/2006 | US20060079568 Inhibition of atherosclerosis by diindolylmethane analogs |
| 04/13/2006 | US20060079567 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 04/13/2006 | US20060079566 Phosphoinositide-dependent kinase-1 (PDK-1) inhibitors; for the treatment and prevention of cancer in humans; 4-[5-(2-Phenanthracenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenecarboxamide |
| 04/13/2006 | US20060079565 Amino acid composition and supplementary liquid containing the same |
| 04/13/2006 | US20060079564 Indazole benzimidazole compounds |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079560 Crystalline form of omeprazole |
| 04/13/2006 | US20060079559 S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079558 R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079557 Sulfamoyl benzamide derivatives and methods of their use |
| 04/13/2006 | US20060079556 metabolic and eating disorders, improvement of cognitive function, substance abuse disorders, cognitive disorders, autoimmune glomerulonephritis |
| 04/13/2006 | US20060079555 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/13/2006 | US20060079554 Inhibitors of monomine uptake |
| 04/13/2006 | US20060079553 Quinoline derivatives as glucokinase ligands |
| 04/13/2006 | US20060079552 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea salt |
| 04/13/2006 | US20060079551 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 04/13/2006 | US20060079550 Amino acid derivatives useful for the treatment of alzheimer's disease |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079547 Thienopyridinone compounds and methods of treatment |
| 04/13/2006 | US20060079546 Aminopiperidine derivatives as antibacterials |
| 04/13/2006 | US20060079545 Palonosetron for the treatment of chemotherapy induced emeses |
| 04/13/2006 | US20060079544 Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
| 04/13/2006 | US20060079543 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis |
| 04/13/2006 | US20060079542 Compounds and methods for treating insulin resistance and cardiomyopathy |
| 04/13/2006 | US20060079541 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 04/13/2006 | US20060079540 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia |
| 04/13/2006 | US20060079539 Synergistic combination |
| 04/13/2006 | US20060079538 selectively inhibiting phosphoinositide 3-kinase delta (PI3K delta ) activity in endothelial cells; example PI3 kinase inhibitor compounds are quinazolin-4-ones such as 5-methyl-3-phenyl-2-[1-(9H-purin-6-yloxy)-ethyl]-3H-quinazolin-4-one |
| 04/13/2006 | US20060079537 2-Substitutued triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same controlling pathogenic fungi, and agents containing said compounds |
| 04/13/2006 | US20060079536 Calcium receptor modulating compound and use thereof |
| 04/13/2006 | US20060079535 Such as 4-(4-Phenoxybutoxy)-7H-furo[3,2-g][1]benzopyran-7-on; autoimmune diseases |
| 04/13/2006 | US20060079534 Cell division inhibitor and a production method thereof |
| 04/13/2006 | US20060079533 Methods of treating alzheimer's disease |
| 04/13/2006 | US20060079532 prophylaxis of gliomas in humans by administering 2,3,5,6-tetramethylpyrazine |
| 04/13/2006 | US20060079531 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 04/13/2006 | US20060079530 Farnesyl transferase inhibitors |
| 04/13/2006 | US20060079529 6-7-8-9-Tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime derivatives such as 5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime; sodium channel modulators; antiischemic agents |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079526 Heterocyclic compounds and methods of use |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079524 Amino substituted aryloxybenzylpiperidine derivatives |
| 04/13/2006 | US20060079523 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 04/13/2006 | US20060079522 Amino substituted aryloxybenzylpiperidine derivatives |
| 04/13/2006 | US20060079521 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
| 04/13/2006 | US20060079520 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/13/2006 | US20060079519 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease. |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | US20060079517 Reverse-turn mimetics and methods relating thereto |
| 04/13/2006 | US20060079516 Highly concentrated stable meloxicam solutions |
| 04/13/2006 | US20060079515 TACE inhibitor in combination with a Src inhibitor, and/or a HER-2 inhibitor such as neratinib |
| 04/13/2006 | US20060079514 Methods and compositions including methscopolamine bromide |
| 04/13/2006 | US20060079513 Methods and compositions including methscopolamine nitrate |
| 04/13/2006 | US20060079512 10-farnesyl-4,6,8-tri(bisbenzyloxyphosphoryloxy)-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one; antitumor, anticarcinogenic agent; solid (pancreatic, prostate, colorectal, lung, ovarian cancer) or hematopoietic (leukemia or lymphoma) neoplasm; bactericide, inhibitor of 5-lipoxygenase, cyclooxygenase-2 |